VA
PASG icon

Verdad Advisers’s Passage Bio PASG Stock Holding History

Verdad Advisers’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$174K Buy
+22,128
New +$229K 0.2% 138

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Verdad Advisers's PASG Position: Q1 2026 in Review

Verdad Advisers opened a new position in Passage Bio (PASG) in Q1 2026: 22,128 shares worth $174K. The stake represents 0.2% of the portfolio and ranks #138 among its holdings.

35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.

  • Verdad Advisers held 22,128 shares of Passage Bio worth $174K as of Q1 2026.
  • Passage Bio was a new Verdad Advisers position in Q1 2026.
  • Passage Bio made up 0.2% of Verdad Advisers's portfolio in Q1 2026, its #138 holding.
  • 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.

Based on Verdad Advisers's 13F filing for Q1 2026, filed 15 May 2026.